Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 467.68B P/E 24.91 EPS this Y 2.60% Ern Qtrly Grth 21.60%
Income 19.16B Forward P/E 17.22 EPS next Y 3.40% 50D Avg Chg 5.00%
Sales 96.04B PEG 4.69 EPS past 5Y 5.93% 200D Avg Chg 4.00%
Dividend 2.00% Price/Book 6.27 EPS next 5Y 3.79% 52W High Chg -4.00%
Recommedations 2.40 Quick Ratio 1.10 Shares Outstanding 2.61B 52W Low Chg 15.00%
Insider Own 0.09% ROA 8.81% Shares Float 2.61B Beta 0.57
Inst Own 70.64% ROE 26.45% Shares Shorted/Prior 12.66M/11.23M Price 178.88
Gross Margin 67.52% Profit Margin 19.95% Avg. Volume 7,081,322 Target Price 183.90
Oper. Margin 26.00% Earnings Date Jan 24 Volume 4,616,637 Change 0.08%

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.

JNJ Chatroom

User Image SweepCast Posted - 42 minutes ago

@SweepCast Unusual Options Observed: $JNJ with our scanner on $180 CALL Expiring: 01-20-2023 worth 121K🐂 ⬅️ SweepCast lets you catch the action in real time. - See Profile for More Info 🏆

User Image stockilluminati Posted - 1 hour ago

$JNJ https://www.stockilluminati.com/jnj/news.php - Dividend Champion, Contender, And Challenger Highlights: Week Of December 4

User Image DividendDiplomats Posted - 3 hours ago

Bert is EYEing down this dividend king on sale. Now that he has hit 100 shares of $JNJ is it time for him to move onto another stock that has also increased dividends for over 50+ years? Stop by and check the video, below! https://youtu.be/L3JBOVu8-Fk

User Image macroaxis Posted - 5 hours ago

$JNJ - Recent Total Risk Alpha is up to 0.09. Price may plunge again. https://www.macroaxis.com/invest/technicalIndicator/JNJ/Total-Risk-Alpha

User Image stockilluminati Posted - 5 hours ago

$JNJ https://www.stockilluminati.com/jnj/news.php - Johnson & Johnson: Time To Buy Before The Split

User Image stockilluminati Posted - 5 hours ago

$JNJ https://www.stockilluminati.com/jnj/news.php - 5 Relatively Safe And Cheap Dividend Stocks To Invest In - December 2022

User Image STCKPRO Posted - 6 hours ago

$JNJ NEW ARTICLE : J&J opts out of Horizon leaving out Amgen, Sanofi as only bidders https://www.stck.pro/news/JNJ/38473165

User Image stockilluminati Posted - 13 hours ago

$JNJ https://www.stockilluminati.com/jnj/news.php - Johnson & Johnson: Time To Buy Before The Split

User Image stockilluminati Posted - 13 hours ago

$JNJ https://www.stockilluminati.com/jnj/news.php - 5 Relatively Safe And Cheap Dividend Stocks To Invest In - December 2022

User Image tickeron Posted - 14 hours ago

$JNJ vs. $LLY: which stock is the best to buy? #JohnsonJohnson https://srnk.us/go/4202619

User Image Robo23 Posted - 15 hours ago

$TMDI Realistically, 3 independent banks perform a comparative analysis with projected 5yr and 10yr growth and earnings. Then, $TMDI does not have any debt and is a research/development company, a comparision with the likes of $JNJ Auris and $ISRG DaVinci is done. Please keep in mind that in all the conferences $TMDI has been involved in, they never compare themselves to Hugo. Not a word-crickets … Banks use certain ratios to come up with figures on valuation. $13 is way to low. PATENTS ALONE ARE WORTH BILLIONS. I understand that the pps at the moment blindsides everyone but REMEMBER, Titan hasn't sold a single robot nor will they, they are solely a research and devekopment company with zero revenue. $MDT or anyone that outbids Martha will bring Enos to market. LONGS HOLD THE LINE.

User Image Outcomes Posted - 16 hours ago

$NRXP Will DOD/DARPA EUA protect $PFE $MRNA $JNJ or will justice be served? And what of FDA/NIH/WHO/CDC/CEPI/Gates etc. 🤔🤔🤔 Beware Big pharma. Beware Bureaucrats.

User Image tickeron Posted - 17 hours ago

$JNJ vs. $PFE: what is the best stock to add to your portfolio? #JohnsonJohnson https://srnk.us/go/4202397

User Image GemsBot Posted - 17 hours ago

6 of 11 $JNJ $JPM $KO The best reward to risk ratio trades are when consecutive bars show dark colored signals … see 7/11

User Image stockilluminati Posted - 18 hours ago

$JNJ https://www.stockilluminati.com/jnj/news.php - Johnson & Johnson: Time To Buy Before The Split

User Image STCKPRO Posted - 19 hours ago

$JNJ NEW ARTICLE : Johnson & Johnson: Time To Buy Before The Split https://www.stck.pro/news/JNJ/38456309

User Image STCKPRO Posted - 20 hours ago

$JNJ NEW ARTICLE : Johnson & Johnson: Boring, But Worth Having In A Portfolio https://www.stck.pro/news/JNJ/38454789

User Image stockilluminati Posted - 20 hours ago

$JNJ https://www.stockilluminati.com/jnj/news.php - Johnson & Johnson: Boring, But Worth Having In A Portfolio

User Image stockilluminati Posted - 23 hours ago

$JNJ https://www.stockilluminati.com/jnj/news.php - IUSV: A Value ETF Outperforming The Market

User Image MarketBeatInsiderTrades Posted - 1 day ago

Johnson & Johnson EVP Ashley Mcevoy Sells $12,865,986.81 in $JNJ https://www.marketbeat.com/i/539157

User Image JacobBaek Posted - 1 day ago

$JNJ funding guys Vaxart finally got the funding Nvax funding made them 4$ to 300$ don’t miss it guys

User Image NasdaqSniper Posted - 1 day ago

$DIA $DJIA $JNJ insider dump buy at $70 level🤓

User Image SweepCast Posted - 1 day ago

@SweepCast Unusual Options Observed: $JNJ with our scanner on $135 CALL Expiring: 01-17-2025 worth 26K🐂 ⬅️ Use this in real-time with @SweepCast - See Profile for More Info 🏆

User Image hoangkc Posted - 1 day ago

The weekly #rrgchart rotations of medical equipment stocks: $BAX $MDT $ABT $JNJ $BSX

User Image fla Posted - 1 day ago

$JNJ [15s. delayed] filed SEC form 4: Insider McEvoy Ashley: Disposed 73,323 of Common Stock at average price $175.47 and Converted secur https://s.flashalert.me/Kqknq

User Image cctranscripts Posted - 1 day ago

EVP of Johnson & Johnson just cashed-in 73,323 options https://www.conferencecalltranscripts.org/summary/?id=11581104 $JNJ

User Image Quantisnow Posted - 1 day ago

$JNJ 📜 SEC Form 4: Mcevoy Ashley sold $12,865,801 worth of shares (73,323 units at $175.47) and exercised 73,323 shares at a strike of $72.54, decreasing direct ownership by 0.00% to 41,813 units https://quantisnow.com/i/3763005?utm_source=stocktwits 45 seconds delayed.

User Image Newsfilter Posted - 1 day ago

$JNJ Form 4 (statement of changes in beneficial ownership of securities) filed with the SEC https://newsfilter.io/a/dc9e015f567b3051f7a38b6f1c23575b

User Image YeNOSadios Posted - 1 day ago

$TMDI $MDT $JNJ

User Image Congratulations Posted - 1 day ago

$VTGN 👈shorts literally doomed here today $JNJ $BRK.A

Analyst Ratings
Morgan Stanley Equal-Weight Dec 1, 22
Credit Suisse Neutral Nov 18, 22
Morgan Stanley Equal-Weight Oct 19, 22
Raymond James Outperform Oct 19, 22
Atlantic Equities Neutral Oct 19, 22
Barclays Equal-Weight Oct 18, 22
Morgan Stanley Equal-Weight Oct 12, 22
Morgan Stanley Equal-Weight Sep 12, 22
UBS Neutral Jul 21, 22
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
McEvoy Ashley EVP, WW Chair, MedTe.. EVP, WW Chair, MedTech Nov 30 Option 72.54 73,323 5,318,850 115,136 12/02/22
McEvoy Ashley EVP, WW Chair, MedTe.. EVP, WW Chair, MedTech Nov 30 Sell 175.77 73,323 12,887,984 41,813 12/02/22
Wengel Kathryn E EVP, Chief GSC Offic.. EVP, Chief GSC Officer Nov 09 Option 72.54 16,410 1,190,381 87,721 11/10/22
Wengel Kathryn E EVP, Chief GSC Offic.. EVP, Chief GSC Officer Nov 09 Sell 173.42 16,410 2,845,822 71,311 11/10/22
Mongon Thibaut Exec VP, WW Chair, C.. Exec VP, WW Chair, Consumer Nov 07 Option 108.77 17,043 1,853,767 57,176 11/09/22
Mongon Thibaut Exec VP, WW Chair, C.. Exec VP, WW Chair, Consumer Nov 04 Option 130.73 35,246 4,607,710 75,379 11/08/22
Mongon Thibaut Exec VP, WW Chair, C.. Exec VP, WW Chair, Consumer Nov 04 Sell 171.18 35,246 6,033,410 40,133 11/08/22
Wengel Kathryn E EVP, Chief GSC Offic.. EVP, Chief GSC Officer Jun 10 Sell 173 40,000 6,920,000 71,311 06/14/22
Wengel Kathryn E EVP, Chief GSC Offic.. EVP, Chief GSC Officer Jun 10 Option 72.54 40,000 2,901,600 111,311 06/14/22
Decker Robert J Controller, CAO Controller, CAO May 26 Option 72.54 8,462 613,833 23,935 05/31/22
Decker Robert J Controller, CAO Controller, CAO May 26 Sell 180 8,462 1,523,160 15,473 05/31/22
Hait William See Remarks See Remarks Apr 21 Option 90.44 29,699 2,685,978 109,935 04/25/22
Hait William See Remarks See Remarks Apr 21 Sell 183.58 29,699 5,452,142 80,236 04/25/22
Gorsky Alex Director Director Jan 14 Option 65.37 231,951 15,162,637 695,601 01/19/22
Duato Joaquin CEO CEO Jan 14 Option 65.37 84,423 5,518,732 280,475 01/19/22
Sneed Michael E EVP, Global Corp Aff.. EVP, Global Corp Aff & COO Dec 10 Option 62.2 54,662 3,399,976 110,741 12/10/20
Sneed Michael E EVP, Global Corp Aff.. EVP, Global Corp Aff & COO Dec 10 Sell 152.93 54,662 8,359,460 56,079 12/10/20